WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...
Annualized height velocity of 9.05 cm/year (LS mean) for TransCon hGH-treated children was similar at Week 52 to daily somatropin-treated children - TransCon hGH showed a safety and tolerability ...
Researchers say they have uncovered more evidence to support a controversial hypothesis that sticky proteins that are a signature of Alzheimer’s disease can be transmitted from person to person ...
Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...
Please provide your email address to receive an email when new articles are posted on . Somapacitan-beco is a once-weekly growth hormone injection. New indications expand treatment options for ...
NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...
NEW YORK (Reuters Health) - Daily injections of growth hormone may help reduce pain and improve the quality of life in some patients with fibromyalgia, new findings of a small study suggest.
The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...
Five people appear to have developed Alzheimer’s disease after receiving growth hormones from deceased donors’ brains as children. Although based on a small group of people, this suggests that the ...
The human growth hormone business is a $2 billion industry. Feb. 12, 2008— -- Marie Miano, like some professional athletes, takes human growth hormone — but she has a prescription. "I feel like a ...
(Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...
New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...